Methimazole Treatment of 262 Cats With Hyperthyroidism

Journal of Veterinary Internal Medicine

Volumn 2, Issue 3, 1988, Pages 150-157

  Peterson, Mark E ^a   Kintzer, Peter P ^a   Hurvitz, Arthur I ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; THIAMAZOLE; THYROXINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CAT; CAT DISEASE; ERYTHROCYTE; FEMALE; HYPERTHYROIDISM; IMMUNOLOGY; MALE; TIME;

ANIMAL; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CAT DISEASES; CATS; ERYTHROCYTES; FEMALE; HYPERTHYROIDISM; MALE; METHIMAZOLE; THYROXINE; TIME FACTORS;

EID: 0024051520     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.1988.tb02812.x     Document Type: Article

References (32)

1. Feline hyperthyroidism: Pretreatment clinical and laboratory evaluation of 131 cases
2. Feline hyperthyroidism
3. Feline hyperthyroidism
4. Antithyroid drugs
5. Surgical treatment of feline hyperthyroidism: Results of 85 cases
6. Propylthiouracil treatment of feline hyperthyroidism
7. Propylthiouracil‐associated hemolytic anemia, thrombocytopenia, and antinuclear antibodies in cats with hyperthyroidism
8. Propylthiouracil‐induced immune‐mediated disease in cats
9. Serum thyroid hormone concentrations fluctuate in cats with hyperthyroidism
10. The thyroid gland
11. Thyroid hormone replacement therapy
12. Propylthiouracil inhibits the conversion of L‐thyroxine to L‐triiodothyronine: An explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active thyroid hormone
13. Triiodothyronine and thyroxine in hyperthyroidism: Comparison of the acute changes during therapy with antithyroid agents
14. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves disease
15. 4, and TSH measurements for management of Graves disease in children
16. Drug‐induced hepatic injury during methimazole therapy
17. Methimazole‐induced jaundice
18. Multiple complications of propylthiouracil treatment: Granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization
19. Hepatotoxicity from antithyroid drugs
20. Agranulocytosis associated with antithyroid drugs: Effects of patient age and drug dose
21. Immune‐mediated disorders of cats
22. Drug‐induced antinuclear antibodies and lupus syndromes
23. Drug‐induced systemic lupus erythematosus: A critical review
24. Drug allergy
25. Methimazole inhibits thyroid autoantibody production by an action on accessory cells
26. Drug‐induced immunological neutropenia
27. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves disease: A possible cause of antithyroid drug‐induced agranulocytosis
28. Drug‐induced liver disease: An overview
29. Single daily dose methimazole treatment of hyperthyroidism
30. Treatment of hyperthyroidism with a small single daily dose of methimazole
31. Intrathyroidal concentrations of methimazole in patients with Graves disease